Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer.

导出 OA

翻译打印收藏纠错

作者： Pierre,Nahon ^[1] ; Maxime,Ronot ^[2] ; Olivier,Sutter ^[2] ; Pierre-André,Natella ^[3] ; Samia,Baloul ^[4] ; Isabelle,Durand-Zaleski ^[5] ; Etienne,Audureau ^[6]

作者单位： APHP, Paris, France pierre.nahon@aphp.fr. ^[1] Radiology Department, APHP, Paris, France. ^[2] Clinical Epidemiology and Ageing, Hôpitaux Universitaires Henri Mondor, Creteil, France. ^[3] Assistance Publique-Hôpitaux de Paris, Paris, France. ^[4] University of Paris, Paris, France.;URCEco, Assistance Publique-Hôpitaux de Paris, Paris, France. ^[5] CEPIA EA7376, Universite Paris-Est Creteil Val de Marne, Creteil, France. ^[6]

关键词 diagnostic imaging hepatobiliary disease hepatobiliary tumours magnetic resonance imaging ultrasonography

主题词人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);肝肿瘤(Liver Neoplasms);磁共振成像(Magnetic Resonance Imaging);肝硬化(Liver Cirrhosis);随机对照试验(主题)(Randomized Controlled Trials as Topic);多中心研究(主题)(Multicenter Studies as Topic)

DOI 10.1136/bmjopen-2023-083701

PMID 38367972

发布时间 2024-12-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交